1184936-21-7 Usage
General Description
4-Chloro-2-(trifluoroacetyl)aniline hydrochloride hydrate is a complex chemical compound that is primarily used in scientific research and experimentation. 4-Chloro-2-(trifluoroacetyl)aniline hydrochloride hydrate is known for its unique chemical properties, including its ability to engage in various types of chemical reactions. It contains four constituent parts, namely chlorine, trifluoroacetyl, aniline and hydrochloride hydrate. The presence of chlorine and trifluoroacetyl lends this compound its reactive properties, while the aniline and hydrochloride hydrate components help stabilize the compound. As a research tool, it's often utilized in experiments related to pharmaceutical development, chemical engineering, and materials science, among others. However, this compound needs to be handled with caution due to potential safety risks.
Check Digit Verification of cas no
The CAS Registry Mumber 1184936-21-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,8,4,9,3 and 6 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1184936-21:
(9*1)+(8*1)+(7*8)+(6*4)+(5*9)+(4*3)+(3*6)+(2*2)+(1*1)=177
177 % 10 = 7
So 1184936-21-7 is a valid CAS Registry Number.
1184936-21-7Relevant articles and documents
Crystalline Efavirenz
-
, (2008/06/13)
The potent reverse transcriptase inhibitor Efavirenz is produced in crystalline form. Crystalline Efavirenz exists in several physical forms which are-designated Forms 1, 2, 3 and 4, and are characterized by x-ray powder diffraction and differential scanning calorimetry. Pharmaceutical compositions and methods are useful for the treatment of the human immunodeficiency virus (HIV).
Asymmetric synthesis of benzoxazinones
-
, (2008/06/13)
The present invention provides novel methods for the asymmetric synthesis of (S)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one of formula (VI-i) STR1 which is useful as a human immunodeficiency virus (HIV) reverse transcriptase inhibitor.